1Topf N, Worgall S, Hackett NR, et al. Regional 'prodrug' gene therapy: Intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.Gene Ther, 1998,5(5):507.
2Hoganson DK, Batra RK, Olsen JC, et al. Comparison of the effects of three different toxin geaes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma. Cancer Res, 1996, 56(6):1315.
3Culver KW, Ram Z, Walbridge S, et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science, 1992,256 (5063) :1550.
4Iwotani Y, Kamigaki T, Suzuki S, et al. Proliferating cell nuclear antigen as a predictor of therapeutic effect of continuous 5-fluorouracil administration in gastric cancer. Int J Oncol, 1999, 14(5): 965.
5Inada T, Ichikawa A, Kubota T, etal. 5-FU-induced apoptosis correlates with efficacy against human gastric and colon cancer xenografts in nude mice. Anticancer Res,1997,17(3C):1965.
6Wang ZH, Samuels S, Gama-Sosa MA, et al. 5-Fluorocytosine-mediated apoptosis and DNA damage in glioma cells engineered to express cytosine deaminase and their enhancement with interferon.J Neurooncol, 1998, 36(3) : 219.
7Bentires-Alj M, Hellin AC, Lechanteur C, et al. Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis. Cancer Gene Ther, 2000,7(1):20.
8Andrade- Rozental AF, Rozental R, Hopperstad MG, et al. Gap junctions:The "kiss of death" and "kiss of life".Brain Res Brain Res Rev, 2000, 32(1): 308.
9O'Malley BW, Li D. Combination gene therapy for salivary gland cancer. Ann N Y Acad Sci 1998,842:163 - 170.
10O'Malley BW,Cope KA,Chen SH, et al. Combination gene therapy for oral cancer in a murine model. Cancer Res 1996,56 (8): 1737 -1741.
